Published in Liver Transpl on February 01, 2005
Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist. Gastroenterol Hepatol (N Y) (2006) 0.75
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology (2005) 3.71
Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants. Transplantation (2011) 2.10
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl (2006) 1.48
Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol (2002) 1.42
Primary biliary cirrhosis and systemic amyloidosis, a new association. Dig Dis Sci (2004) 1.40
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology (2002) 1.33
The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis (2002) 1.19
Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl (2010) 1.19
Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Hum Gene Ther (2010) 1.18
Emerging evidence of hepatitis C virus neuroinvasion. AIDS (2005) 1.14
Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl (2005) 1.14
Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood (2004) 1.13
Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology (2004) 1.12
Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl (2009) 1.10
Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol (2004) 1.09
Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation (2004) 1.09
Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl (2002) 1.04
Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors? Dig Dis Sci (2004) 0.97
Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis (2004) 0.95
Recent advances in liver transplantation. Mayo Clin Proc (2003) 0.94
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci (2013) 0.93
Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci (2008) 0.92
Cancer antigen 125 in patients with chronic liver disease. Mayo Clin Proc (2002) 0.91
Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant (2012) 0.90
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology (2002) 0.89
Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant (2015) 0.89
Pegylated interferon and ribavirin failures: is retreatment an option? Dig Dis Sci (2007) 0.87
Liver transplantation in China. Liver Transpl (2007) 0.86
Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol (2012) 0.86
Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women. J Infect Dis (2005) 0.86
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation. Clin Transplant (2014) 0.85
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (2008) 0.84
Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl (2003) 0.84
Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci (2002) 0.84
Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement. J Clin Gastroenterol (2009) 0.83
New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. J Transplant (2013) 0.83
Living donor liver transplantation in polycystic liver disease. Liver Transpl (2008) 0.83
Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci (2006) 0.83
An unusual occurrence of giant cell hepatitis. Liver Transpl (2009) 0.83
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation (2003) 0.82
Differential display analysis of gene expression in brains from hepatitis C-infected patients. AIDS (2005) 0.82
A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl (2002) 0.82
Conflict of interest policy. Hepatology (2008) 0.81
Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Transplantation (2010) 0.80
Management of pre-liver transplantation patient--part 2. Liver Transpl (2005) 0.80
Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome. Rev Med Chil (2012) 0.79
The use of hepatitis C-infected grafts in liver transplantation. Liver Transpl (2003) 0.79
Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci (2004) 0.79
Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol (2005) 0.79
Hepatitis C virus infection with hepatocellular carcinoma: not a controversial indication for liver transplantation. Transplantation (2004) 0.78
Virologically compromised donor grafts in liver transplantation. J Hepatol (2004) 0.78
Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci (2008) 0.78
Artificial neural network and tissue genotyping of hepatocellular carcinoma in liver-transplant recipients: prediction of recurrence. Transplantation (2005) 0.77
Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy. Dig Dis Sci (2006) 0.76
Intestinal and multivisceral transplantation: dynamics of nutritional management and functional autonomy. JPEN J Parenter Enteral Nutr (2003) 0.76
Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant (2010) 0.75
Hepatitis E infection in liver transplant recipients. Liver Transpl (2014) 0.75
Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations. Diabetes Metab Res Rev (2010) 0.75
Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging (2015) 0.75
Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy. Am J Gastroenterol (2008) 0.75
Corrigendum: Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Am J Gastroenterol (2016) 0.75
A message from the editors: Thank you. Liver Transpl (2009) 0.75
Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients. Nutr Clin Pract (2014) 0.75
A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C. Dig Dis Sci (2002) 0.75